Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users
Javier Carbone(Hospital General Universitario Gregorio Marañón), Eduardo Fernández‐Cruz, José M. Benito(Hospital Universitario Rey Juan Carlos), J. Navarro(Hospital General Universitario Gregorio Marañón), J M Zabay(Hospital General Universitario Gregorio Marañón), Joaquín Bartolomé(Hospital General Universitario Gregorio Marañón), Juana Gil(Hospital General Universitario Gregorio Marañón), Francisco Valverde López(Nufarm (Australia))
Cited by 75
Related Papers
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
|The Lancet Respiratory Medicine|2022|127
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection
|AIDS|2004|115
CD38 Expression on CD8 T Lymphocytes as a Marker of Residual Virus Replication in Chronically HIV-Infected Patients Receiving Antiretroviral Therapy
|AIDS Research and Human Retroviruses|2004|95
Differential Upregulation of CD38 on Different T-Cell Subsets May Influence the Ability to Reconstitute CD4+ T Cells Under Successful Highly Active Antiretroviral Therapy
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2005|92